Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-53,059
Closed -$3.83M 285
2024
Q4
$3.83M Buy
53,059
+47,694
+889% +$3.73M 0.13% 180
2024
Q3
$437K Buy
+5,365
New +$429K 0.02% 390
2022
Q1
Sell
-100,854
Closed -$7.72M 288
2021
Q4
$7.72M Buy
100,854
+4,516
+5% +$332K 0.58% 31
2021
Q3
$7.11M Buy
+96,338
New +$7.22M 0.67% 24

Other funds holding HOLX

Crestline Management's HOLX Position: Q1 2025 in Review

Crestline Management sold out of Hologic (HOLX) in Q1 2025, closing a stake of 53,059 shares — an estimated $3.83M sold.

Crestline Management first reported a position in HOLX in Q3 2021 and held it in 4 quarters. The position peaked at $7.72M in Q4 2021. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Crestline Management reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 53,059 Hologic shares in Q1 2025, an estimated $3.83M.
  • Crestline Management first reported a position in Hologic in Q3 2021 and held it in 4 quarters.
  • Crestline Management's Hologic position peaked at $7.72M in Q4 2021.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.